Steven Cohen Guardant Health, Inc. Call Options Transaction History
Point72 Asset Management, L.P.
- $44.6 Billion
- Q2 2025
Call Options
3 transactions
Others Institutions Holding GH
# of Institutions
416Shares Held
127MCall Options Held
1.51MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.2MShares$732 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$676 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$299 Million0.05% of portfolio
-
Baillie Gifford & CO4.81MShares$289 Million0.2% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.25MShares$256 Million7.85% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $6.15B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...